Ryder & BJC Health System Secure SMI Collaboration Award for Transforming Healthcare Supply Chain, Enhancing Patient Care
Strategic Collaboration Delivers Near 100% Fulfillment Rates, 100% Real-Time Visibility, and Resilient Medical Logistics Across 14 Hospitals MIAMI–(BUSINESS... Read more.
Bullish Reports Third Quarter 2025 Results
Bullish posts record Adjusted Revenue, Adjusted EBITDA, and Adjusted Net Income for Q3’2025 Bullish beats guided ranges on Subscription, Services, & Other... Read more.
Merck Announces Positive Topline Results from the Pivotal Phase 3 Trial Evaluating Investigational, Once-Daily, Oral, Two-Drug, Single-Tablet Regimen of Doravirine/Islatravir (DOR/ISL) in Treatment-Naïve Adults with HIV-1 Infection
Investigational DOR/ISL is the first non-INSTI, two-drug regimen to demonstrate non-inferiority to BIC/FTC/TAF in a Phase 3 clinical trial in treatment-naïve adults... Read more.
RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. Announces Preliminary Results of Rights Offering
WEST PALM BEACH, Fla.–(BUSINESS WIRE)–RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. (the “Fund”) (NYSE: OPP) today announced the preliminary... Read more.
CMOs Face a ‘Reputation and Results’ Reckoning, According to NIQ’s 2026 Outlook
Despite economic volatility, 83% of marketing leaders remain confident in their brands but cite ROI proof and data connectivity as top challenges, NIQ finds. CHICAGO–(BUSINESS... Read more.
Fluid Biomed Appoints Veteran MedTech Executive John Kilcoyne as Independent Board Chair
Appointment expands the company’s leadership expertise as Fluid Biomed advances development of its polymer-based stent technology to treat brain aneurysms and... Read more.
Easterly Government Properties to Participate in Jefferies Real Estate Conference 2025
WASHINGTON–(BUSINESS WIRE)–Easterly Government Properties, Inc. (NYSE: DEA) (the “Company” or “Easterly”), a fully integrated real estate investment... Read more.
Alzheon to Present Multiple Clinical, Neuroimaging and Modeling Results for Oral Valiltramiprosate/ALZ-801 from Phase 2 and 3 Studies at CTAD Conference in San Diego, December 1–4, 2025
Valiltramiprosate Demonstrates Potential as the First Oral Disease-Modifying Agent to Slow Alzheimer’s Pathology, Indicated by Both Clinical and Volumetric MRI... Read more.
PIF’s The Helicopter Company, Archer Aviation, and Red Sea Global Partner to Launch eVTOL Air Mobility in Saudi Arabia
The Helicopter Company (THC), a subsidiary of Saudi Arabia’s Public Investment Fund (PIF), selected leading eVTOL OEM Archer to bring their Midnight air taxi to... Read more.
Eurofins: Director/PDMR Shareholding
LUXEMBOURG–(BUSINESS WIRE)–Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities... Read more.